96 related articles for article (PubMed ID: 19470820)
1. Acute increases in murine tumor echogenicity after antivascular ultrasound therapy: a pilot preclinical study.
Wood AK; Bunte RM; Schultz SM; Sehgal CM
J Ultrasound Med; 2009 Jun; 28(6):795-800. PubMed ID: 19470820
[TBL] [Abstract][Full Text] [Related]
2. The antivascular action of physiotherapy ultrasound on a murine tumor: role of a microbubble contrast agent.
Wood AK; Bunte RM; Cohen JD; Tsai JH; Lee WM; Sehgal CM
Ultrasound Med Biol; 2007 Dec; 33(12):1901-10. PubMed ID: 17720299
[TBL] [Abstract][Full Text] [Related]
3. The antivascular action of physiotherapy ultrasound on murine tumors.
Wood AK; Ansaloni S; Ziemer LS; Lee WM; Feldman MD; Sehgal CM
Ultrasound Med Biol; 2005 Oct; 31(10):1403-10. PubMed ID: 16223644
[TBL] [Abstract][Full Text] [Related]
4. Histopathological observations of the antivascular effects of physiotherapy ultrasound on a murine neoplasm.
Bunte RM; Ansaloni S; Sehgal CM; Lee WM; Wood AK
Ultrasound Med Biol; 2006 Mar; 32(3):453-61. PubMed ID: 16530105
[TBL] [Abstract][Full Text] [Related]
5. The disruption of murine tumor neovasculature by low-intensity ultrasound-comparison between 1- and 3-MHz sonication frequencies.
Wood AK; Bunte RM; Price HE; Deitz MS; Tsai JH; Lee WM; Sehgal CM
Acad Radiol; 2008 Sep; 15(9):1133-41. PubMed ID: 18692754
[TBL] [Abstract][Full Text] [Related]
6. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations.
Gee MS; Saunders HM; Lee JC; Sanzo JF; Jenkins WT; Evans SM; Trinchieri G; Sehgal CM; Feldman MD; Lee WM
Cancer Res; 2001 Apr; 61(7):2974-82. PubMed ID: 11306476
[TBL] [Abstract][Full Text] [Related]
7. Combination of HIFU therapy with contrast-enhanced sonography for quantitative assessment of therapeutic efficiency on tumor grafted mice.
Rouffiac V; Duret JS; Péronneau P; Dehez N; Opolon P; Roche A; Lassau N
Ultrasound Med Biol; 2006 May; 32(5):729-40. PubMed ID: 16677932
[TBL] [Abstract][Full Text] [Related]
8. Antivascular ultrasound therapy extends survival of mice with implanted melanomas.
Wood AK; Schultz SM; Lee WM; Bunte RM; Sehgal CM
Ultrasound Med Biol; 2010 May; 36(5):853-7. PubMed ID: 20381952
[TBL] [Abstract][Full Text] [Related]
9. Antivascular ultrasound therapy: magnetic resonance imaging validation and activation of the immune response in murine melanoma.
Hunt SJ; Gade T; Soulen MC; Pickup S; Sehgal CM
J Ultrasound Med; 2015 Feb; 34(2):275-87. PubMed ID: 25614401
[TBL] [Abstract][Full Text] [Related]
10. Treatment of murine tumors using dual-frequency ultrasound in an experimental in vivo model.
Barati AH; Mokhtari-Dizaji M; Mozdarani H; Bathaie SZ; Hassan ZM
Ultrasound Med Biol; 2009 May; 35(5):756-63. PubMed ID: 19195770
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of blood flow in the mouse Achilles tendon using high-frequency ultrasound.
Yeh CK; Chen JJ; Li ML; Luh JJ; Chen JJ
Ultrasonics; 2009 Feb; 49(2):226-30. PubMed ID: 18835004
[TBL] [Abstract][Full Text] [Related]
12. Ablation of high intensity focused ultrasound combined with SonoVue on rabbit VX2 liver tumors: assessment with conventional gray-scale US, conventional color/power Doppler US, contrast-enhanced color Doppler US, and contrast-enhanced pulse-inversion harmonic US.
Luo W; Zhou X; He G; Li Q; Zheng X; Fan Z; Liu Q; Yu M; Han Z; Zhang J; Qian Y
Ann Surg Oncol; 2008 Oct; 15(10):2943-53. PubMed ID: 18612702
[TBL] [Abstract][Full Text] [Related]
13. Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors.
Iordanescu I; Becker C; Zetter B; Dunning P; Taylor GA
Radiology; 2002 Feb; 222(2):460-7. PubMed ID: 11818614
[TBL] [Abstract][Full Text] [Related]
14. Monitoring angiogenesis in human melanoma xenograft model using contrast-enhanced ultrasound imaging.
Forsberg F; Ro RJ; Liu JB; Lipcan KJ; Potoczek M; Nazarian LN
Ultrason Imaging; 2008 Oct; 30(4):237-46. PubMed ID: 19507677
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging].
Schröder RJ; Bostanjoglo M; Hidajat N; Rademaker J; Röttgen R; Mäurer J; Felix R
Rofo; 2002 Sep; 174(9):1132-41. PubMed ID: 12221572
[TBL] [Abstract][Full Text] [Related]
16. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization.
Peronneau P; Lassau N; Leguerney I; Roche A; Cosgrove D
Ultraschall Med; 2010 Aug; 31(4):370-8. PubMed ID: 20577941
[TBL] [Abstract][Full Text] [Related]
17. Selective depletion of tumor neovasculature by microbubble destruction with appropriate ultrasound pressure.
Wang J; Zhao Z; Shen S; Zhang C; Guo S; Lu Y; Chen Y; Liao W; Liao Y; Bin J
Int J Cancer; 2015 Nov; 137(10):2478-91. PubMed ID: 25951495
[TBL] [Abstract][Full Text] [Related]
18. Validation of a new method for quantifying in vivo murine tumor necrosis by sonography.
Rouffiac V; Bouquet C; Lassau N; Opolon P; Koscielny S; Peronneau P; Perricaudet M; Roche A
Invest Radiol; 2004 Jun; 39(6):350-6. PubMed ID: 15167101
[TBL] [Abstract][Full Text] [Related]
19. Quantification of tumor vascularity and flow with amplitude color Doppler sonography in an experimental model: preliminary results.
Meyerowitz CB; Fleischer AC; Pickens DR; Thurman GB; Borowsky AD; Thirsk G; Hellerqvist CG
J Ultrasound Med; 1996 Dec; 15(12):827-33. PubMed ID: 8947858
[TBL] [Abstract][Full Text] [Related]
20. Power Doppler assessment of vascular changes during fracture treatment with low-intensity ultrasound.
Rawool NM; Goldberg BB; Forsberg F; Winder AA; Hume E
J Ultrasound Med; 2003 Feb; 22(2):145-53. PubMed ID: 12562119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
